About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming the treatment landscape for central nervous system (CNS) disorders. Our commitment to innovation drives us to identify and bridge critical care gaps, developing differentiated therapeutic solutions with unique mechanisms of action that significantly enhance patient outcomes. Our robust neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness due to narcolepsy and obstructive sleep apnea, migraines, and several late-stage clinical programs targeting a wide array of serious neurological and psychiatric conditions affecting over 150 million individuals across the United States. Together, we are dedicated to tackling some of the most challenging issues related to brain health, allowing patients and their families to thrive.

